Prebiotic‐Based Nanoamorphous Atorvastatin Attenuates Nonalcoholic Fatty Liver Disease by Retrieving Gut and Liver Health
Jin‐Jin Cui(Chinese Academy of Medical Sciences & Peking Union Medical College), Lu-Lu Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Haoyang Yu(Guilin Medical University), Xiaolei Ma, Zhigang Luo(Guangzhou University), Wensheng Zheng(Chinese Academy of Medical Sciences & Peking Union Medical College), Yongsheng Che(Chinese Academy of Medical Sciences & Peking Union Medical College), Rui Li(Wannan Medical College), Peng Du(Gansu University of Traditional Chinese Medicine), Xiao Ding(Kunming Institute of Botany), Xiuping Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian‐Dong Jiang(Ningbo University)
Cited by 0
Related Papers
Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells
|International Journal of Biological Sciences|2021|425
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
|Cancer Cell|2005|368
Protein kinase C controls lysosome biogenesis independently of mTORC1
|Nature Cell Biology|2016|359
Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients
|Signal Transduction and Targeted Therapy|2021|210